Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors
Monoamine oxidase inhibitors (MAOI) are a class of drugs that were originally developed for the treatment of depression but have since been expanded to be used in management of affective and neurological disorders, as well as stroke and aging-related neurocognitive changes. Ranging from irreversible...
Saved in:
Main Authors: | Amber N. Edinoff, Connor R. Swinford, Amira S. Odisho, Caroline R. Burroughs, Cain W. Stark, Walid A. Raslan, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-11-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.39576 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Influence of Monoamine Oxidase Variants on the Risk of Betel Quid-Associated Oral and Pharyngeal Cancer
by: Ping-Ho Chen, et al.
Published: (2014-01-01) -
Phenothiazines and their Evolving Roles in Clinical Practice: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01) -
Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia
by: Kunal Maini, et al.
Published: (2021-06-01) -
Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
by: Amber N. Edinoff, et al.
Published: (2022-08-01) -
Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities
by: Amber N. Edinoff, et al.
Published: (2022-09-01)